33.6 C
Vientiane
Sunday, August 24, 2025
spot_img
Home Blog Page 642

Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development

Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability

SINGAPORE, May 7, 2025 /PRNewswire/ — Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), National University Hospital (NUH) and the National University Health System (NUHS) today announced a research and development collaboration to advance outcomes in human health and sustainability. Flagship, NUS Medicine, NUH and NUHS outlined the goals of their collaboration via a Memorandum of Understanding (MOU) signed this week.

Flagship, NUS Medicine, NUH and NUHS expect to create, co-develop and co-resource a series of research projects over an initial five-year horizon, tapping into opportunities across Flagship’s existing ecosystem of over 40 companies, and future companies founded by Flagship. Through potential secondments, internships and participation in the Flagship Fellowship program, the collaboration will also create career development and mentorship opportunities for scientists and students of NUS Medicine with Flagship.

In addition, Flagship will tap into the ecosystem of NUH and NUHS to leverage clinical data for new biological insights, test clinical hypotheses for novel impact and improved patient outcomes.  

“Our collaboration with NUS Medicine, NUH and NUHS will help us realize our goal to expand the global reach and impact of Flagship and its companies and serve as an anchor in Singapore and throughout Asia Pacific for globally connected life science innovation,” said André Andonian, Chair of Asia Pacific and Strategic Advisor, Flagship Pioneering. “We are pleased to combine Flagship’s signature approach to company creation and development with the scientific expertise, data reach and translational potential of NUS Medicine, NUH and NUHS. Along with our previously announced collaboration with the Agency for Science, Technology and Research (A*STAR), our work with NUS Medicine, NUH and NUHS has the potential to bring together key players across Singapore’s biotech ecosystem to advance breakthroughs that impact patients and the planet.”

“As integral parts of the NUHS academic health system, NUS Medicine and NUH are uniquely positioned to translate groundbreaking biomedical research seamlessly into real-world clinical solutions,” said Professor Chong Yap Seng, Dean, NUS Medicine, and Deputy Chief Executive (Education & Research), NUHS. “Through this partnership with Flagship, we aim to drive greater innovation and bridge the gap between discovery and patient care. Together, we can shape a future where practice-changing innovations and transformative health solutions can benefit patients, communities and the world.”

About Flagship Pioneering

Flagship Pioneering invents and builds bioplatform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $60 billion in aggregate value. Flagship is operating with $14 billion of assets under management as of its latest capital raise, announced in July 2024. The current Flagship ecosystem comprises over 40 companies, including Foghorn Therapeutics (NASDAQ: FHTX), Moderna (NASDAQ: MRNA), Sana Biotechnology (NASDAQ: SANA), Generate BiomedicinesInariIndigo Agriculture, Lila Sciences, and Tessera Therapeutics.

About National University of Singapore (NUS)

The National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education, research, and entrepreneurship, with a focus on Asian perspectives and expertise. NUS has 16 colleges, faculties, and schools across three campuses in Singapore, with more than 40,000 students from 100 countries enriching its vibrant and diverse campus community. NUS has also established more than 20 NUS Overseas Colleges entrepreneurial hubs around the world.

NUS’s multidisciplinary and real-world approach to education, research and entrepreneurship enables it to work closely with industry, governments, and academia to address crucial and complex issues relevant to Asia and the world. Researchers in its faculties, research centres of excellence, corporate labs and more than 30 university-level research institutes focus on themes that include energy; environmental and urban sustainability; treatment and prevention of diseases; active ageing; advanced materials; risk management and resilience of financial systems; Asian studies; and Smart Nation capabilities such as artificial intelligence, data science, operations research, and cybersecurity.

For more information on NUS, please visit http://www.nus.edu.sg/

About the NUS Yong Loo Lin School of Medicine (NUS Medicine)

The NUS Yong Loo Lin School of Medicine is Singapore’s first and largest medical school. Its enduring mission centres on nurturing highly competent, values-driven, and inspired healthcare professionals to transform the practice of medicine and improve health around the world.

Through a dynamic and future-oriented five-year curriculum that is inter-disciplinary and inter-professional in nature, NUS Medicine students undergo a holistic learning experience that exposes them to multiple facets of healthcare and prepares them to become visionary leaders and compassionate doctors and nurses of tomorrow. Since the School’s founding in 1905, more than 12,000 graduates have passed through its doors.

In pursuit of health for all, NUS Medicine’s strategic research programmes focus on innovative, cutting-edge biomedical research with collaborators around the world to deliver high impact solutions to benefit human lives.

The School is the oldest institution of higher learning in the National University of Singapore and a founding institutional member of the National University Health System. It is one of the leading medical schools in Asia and ranks among the best in the world (Times Higher Education World University Rankings 2025 by subject and the Quacquarelli Symonds (QS) World University Rankings by subject 2024).

For more information about NUS Medicine, please visit https://medicine.nus.edu.sg/

About the National University Hospital 

The National University Hospital (NUH) is Singapore’s leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.

Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.

We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.

The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore.

About the National University Health System

The National University Health System (NUHS) aims to transform how illness is prevented and managed by discovering causes of disease, development of more effective treatments through collaborative multidisciplinary research and clinical trials, and creation of better technologies and care delivery systems in partnership with others who share the same values and vision.

Institutions in the NUHS Group include the National University Hospital, Ng Teng Fong General Hospital, Jurong Community Hospital, Alexandra Hospital and the upcoming Tengah General and Community Hospital; three National Specialty Centres – National University Cancer Institute, Singapore (NCIS), National University Heart Centre, Singapore (NUHCS) and National University Centre for Oral Health, Singapore (NUCOHS); the National University Polyclinics (NUP); Jurong Medical Centre; and three NUS health sciences schools – NUS Yong Loo Lin School of Medicine (including the Alice Lee Centre for Nursing Studies), NUS Faculty of Dentistry and NUS Saw Swee Hock School of Public Health.

With member institutions under a common governance structure, NUHS creates synergies for the advancement of health by integrating patient care, health science education and biomedical research. As a Regional Health System, NUHS works closely with health and social care partners across Singapore to develop and implement programmes that contribute to a healthy and engaged population in the Western part of Singapore.

For more information, please visit www.nuhs.edu.sg.

Media Contacts:

Flagship Pioneering
press@flagshippioneering.com  

NUHS/NUH
Joan Chew
Email: joan_chew@nuhs.edu.sg  

NUS Yong Loo Lin School of Medicine
Sally Toh
Email: sally.toh@nus.edu.sg  

HIGHLY Showcases Next-Gen Lightweight Thermal Management Solutions at Auto Shanghai 2025

SHANGHAI, May 7, 2025 /PRNewswire/ — At the Auto Shanghai 2025, HIGHLY (Shanghai Highly Group Co., Ltd.), a global leader in new energy vehicle (NEV) thermal management systems, unveiled its breakthrough lightweight, integrated solutions tailored for next-generation electric vehicles. The highlights include the R290 Refrigerant Thermal Management ModuleLow-Temperature Heat Pump Self-Heating Compressor, and Low-Temperature Heat Pump Integrated Compressor, reinforcing HIGHLY’s technological leadership in eco-friendly, high-efficiency automotive thermal management.

R290 Refrigerant Module: Compact, Green, and Safer
Designed to meet stringent global environmental standards, the R290 module uses natural propane refrigerant (GWP≈3), reducing carbon footprint while ensuring safety with a sub-150g charge. Through structural optimization and integrated casting, the module cuts volume and weight by 10% versus predecessors. Its ultra-thin flow channel plates (10.5mm average thickness) and embedded control systems enhance space efficiency and energy management.

Cold-Climate Innovation: Dual Compressor Solutions
Addressing extreme cold challenges, HIGHLY launched two compressor breakthroughs:

  1. Self-Heating Compressor: Enables reliable operation at -40°C via optimized motor heating and anti-liquid impact design, extending lifespan by 10%.
  2. Integrated Compressor: Combines self-heating with a printed heating membrane for rapid warming, achieving 15% weight reduction and full-scenario thermal efficiency. Both solutions overcome traditional -10°C heating limits, ensuring NEV performance in harsh environments.

Accelerating NEV Market Leadership
With China’s NEV sales hitting 12.87 million units in 2024 (35.5% YoY growth), HIGHLY is expanding its global footprint across 24 plants and 6 R&D centers in 11 countries. Its new Wuhu production line, operational since 2024, leverages smart manufacturing to meet soaring demand, aligning with industry trends toward sustainability and integration.

HIGHLY’s innovations underscore its commitment to driving the EV revolution through cutting-edge thermal management technologies, supporting global automakers in achieving energy efficiency, safety, and carbon neutrality goals.

Bee Choo Origin Strengthens CSR Efforts with Electric Van Donation to NKF


SINGAPORE – Media OutReach Newswire – 7 May 2025 – Bee Choo Origin, Singapore’s leading herbal hair care brand that specialises in hair fall treatment and oily scalp treatment, has reaffirmed its commitment to corporate social responsibility (CSR) with the donation of an electric passenger van to The National Kidney Foundation (NKF). This marks a significant step in enhancing patient mobility while promoting sustainable transport solutions.

Bee Choo Origin Strengthens CSR Efforts with Electric Van Donation to NKF
Bee Choo Origin Strengthens CSR Efforts with Electric Van Donation to NKF

This donation is part of the long tradition of Bee Choo Origin supporting NKF, reflecting its dedication to making a positive impact beyond the beauty industry. The electric van, which is the first of its kind in NKF’s fleet, will be used to provide transportation for kidney patients who require regular dialysis treatments but face difficulties commuting to and from medical centres.

Providing Safe and Eco-Friendly Transport for Kidney Patients
The donation from Bee Choo Origin supports NKF’s Wheeling for Love & Hope Programme, which provides free transport services to patients struggling with mobility issues. The new electric van is designed with built-in access steps and spacious seating, ensuring safe and comfortable travel for patients. It is expected to facilitate up to 1,044 trips annually, benefiting approximately 72 patients per week.

For many kidney patients, travelling to dialysis centres three times a week can be physically demanding and financially burdensome. NKF’s transport programme alleviates this challenge, offering patients reliable and accessible transportation at no cost. The introduction of an electric van further enhances this initiative by reducing carbon emissions and lowering operational costs in the long run.

“We’re deeply honoured to partner with NKF on this meaningful initiative,” said Ms. Lim Xue Ting, General Manager of Bee Choo Origin. “Dialysis is a lifeline for many, and we hope this contribution helps ease the journey for patients while also supporting a greener, more sustainable future. At Bee Choo Origin, community care and environmental responsibility are values we hold close, and this donation is a reflection of our ongoing commitment to both.”

Bee Choo Origin: A Legacy of Giving Back
Bee Choo Origin has been a steadfast supporter of NKF for several years, previously donating five dialysis machines since 2018 to enhance treatment capacity. The latest contribution of an electric van builds upon this partnership, reinforcing the brand’s dedication to social good.

Beyond its work with NKF, Bee Choo Origin has actively supported various charitable organisations through its CSR initiatives, including:

  • Cerebral Palsy Alliance Singapore (CPAS) – Through their partnership with the Goodwill, Rehabilitation & Occupational Workshop (GROW), Bee Choo Origin contributes to empowering individuals with cerebral palsy by supporting initiatives that promote meaningful employment, skills development, and greater independence.
  • Metta Welfare Association – Bee Choo Origin supports Metta’s programmes and the Maitri School, which focuses on uplifting individuals with special needs through tailored education, dedicated care, and inclusive community engagement.
  • A Packet of Rice – By sponsoring meals, Bee Choo Origin helps provide essential nourishment to underprivileged individuals and families across Singapore, contributing to food security and community welfare.

In 2019, the brand’s founder, Mdm Cheah Bee Chew, personally donated $150,000 from the sales proceeds of her biography to multiple social causes, demonstrating her deep-rooted belief in philanthropy.

A Commitment to Sustainability and Future CSR Initiatives
As Bee Choo Origin celebrates its 25th anniversary, the brand is looking ahead to more initiatives that align with both environmental responsibility and community welfare. The transition to electric transport solutions is a step towards reducing carbon footprints while improving the quality of life for those in need.

“We believe that businesses have a responsibility to contribute to society in meaningful ways,” added Ms. Lim Xue Ting. “Every act of kindness, no matter how small, can make a difference. We hope our contributions inspire other companies and individuals to support those in need.”

Moving forward, the brand’s CSR efforts will continue to focus on improving lives and giving back to the community. Plans are already underway for future community initiatives, reinforcing the brand’s mission of creating lasting positive change.Hashtag: #BeeChooOrigin


The issuer is solely responsible for the content of this announcement.

About Bee Choo Origin

Founded in 2000, Bee Choo Origin is Singapore’s leading hair care brand, specialising in natural, chemical-free herbal hair treatment for hair loss and scalp health. With a commitment to quality and innovation, Bee Choo Origin has expanded globally, offering effective treatments backed by traditional Chinese herbs and modern science. Beyond hair care, the brand actively supports community initiatives, including healthcare and sustainability efforts, reinforcing its dedication to making a positive impact in both beauty and society.

Trend Micro Delivers AI-Powered Threat Detection with AWS Infrastructure Support and NVIDIA Integration

Proactive security with AI-powered model built for modern enterprise workloads


HONG KONG SAR – Media OutReach Newswire – 7 May 2025 – Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today announced new AI-powered threat detection capabilities designed specifically for enterprises embracing AI at scale. This effort brings together Trend’s deep security expertise with NVIDIA accelerated computing and NVIDIA AI Enterprise software, leveraging AWS infrastructure to support scalable, enterprise-ready deployment.

The solution is built to help organizations secure AI-driven workloads and business processes without compromising performance or flexibility. As enterprises scale their AI ambitions from generative AI (GenAI) to agentic AI, new attack surfaces emerge, including threats of data theft, sabotage, and disruption.

To head off the threat of data theft, sabotage, and disruption, Trend is launching a new AI Detection Model leveraging the NVIDIA Morpheus AI framework, part of NVIDIA AI Enterprise, deployed on scalable, high-performance AWS cloud infrastructure.

Trend selected AWS for its global availability, integrated security, and compliance-ready architecture, while NVIDIA provides advanced AI frameworks and the computing power needed to run detection models with unmatched speed and precision. This tightly integrated architecture enables real-time analysis of vast data streams for faster, more precise threat detection.

Chris Grusz, Managing Director, Technology Partnerships for AWS: “Built on AWS’s cloud-native infrastructure, Trend’s platform takes full advantage of NVIDIA AI software and accelerated computing capabilities to power scalable, low-latency threat detection. With AWS’s global footprint and integrated services, Trend can securely process telemetry at scale, adapt detection models to evolving threats, and support customers worldwide—all while accelerating time to value.”

Beyond this integration, other elements of the Trend Vision One™ platform also leverage AWS AI services such as Amazon Bedrock, supporting Workbench Insights to improve investigation workflows and provide deeper context for SOC teams during incident response.

Kevin Simzer, COO at Trend Micro: “AI is reshaping the enterprise, and security has to evolve just as fast. We’re bringing together best-in-class partners in both cloud and AI to deliver something truly differentiated. AWS’s secure and resilient infrastructure gives us the scale, performance, and global availability needed to meet the always-on demands of today’s enterprises. So our customers can detect and respond to threats faster, with confidence.”

To meet these challenges, Trend’s new anomaly detection capability applies AI models built on NVIDIA Morpheus to identify never-before-seen patterns in telemetry and logs. Powered by AWS, the solution rapidly scales across massive data sets, enabling Trend Vision OneTM to build customer-specific detection models that prioritize the most critical events for faster response by security teams.

Strategic technology highlights include:

  • NVIDIA Morpheus Digital Fingerprinting: Identifies subtle anomalies to enable proactive detection of unknown threats.
  • NVIDIA RAPIDS: Accelerate large-scale data classification, enabling real-time detection and prevention of sensitive information leakage.
  • AWS Cloud-Native Architecture: Trend Vision One platform runs natively on AWS, benefiting from the elasticity, global availability, and built-in security of AWS services. This foundation allows for continuous innovation in AI-powered detection while meeting enterprise performance and compliance requirements.

Robert Miller, VP of Corporate Security at Sierra-Cedar: “We’re dealing with an increasingly complex environment with more data. Trend stands out as it doesn’t just provide threat intelligence, it helps make sense of it. Our team can access Trend’s AI-powered platform directly via AWS Marketplace, streamlining procurement and deployment across global cloud environments. This powerful combination allows us to strengthen our security posture and identify threats much faster than we could manually.”

To learn more about Trend Micro’s AI security strategy, please visit: https://documents.trendmicro.com/assets/white_papers/wp-security-for-ai-blueprint-for-your-datacenter-and-cloud.pdf


Hashtag: #trendmicro




The issuer is solely responsible for the content of this announcement.

Trend Micro

Trend Micro, a global cybersecurity leader, helps make the world safe for exchanging digital information. Fueled by decades of security expertise, global threat research, and continuous innovation, Trend Micro’s cybersecurity platform protects hundreds of thousands of organizations and millions of individuals across clouds, networks, devices, and endpoints. As a leader in cloud and enterprise cybersecurity, the platform delivers a powerful range of advanced threat defense techniques optimized for environments like AWS, Microsoft, and Google, and central visibility for better, faster detection and response. With 7,000 employees across 65 countries, Trend Micro enables organizations to simplify and secure their connected world.

Britishpedia Honours Family Podiatry Centre Founder, Mark Reyneker, As a Success Icon

SINGAPORE, May 7, 2025 /PRNewswire/ — Mark Reyneker, founder of the Family Podiatry Centre, will be featured in the 7th Edition of Britishpedia’s “Successful People in Malaysia and Singapore.” He has been recognised for his significant contributions to podiatry in Singapore and Malaysia, highlighting his dedication to innovation, patient care, and the advancement of the field in the region.

Under Reyneker’s leadership, the Family Podiatry Centre has consistently been at the forefront of podiatry development. As a pioneer in the field, Reyneker founded one of the first private podiatry practices in Singapore, played a key role in establishing Malaysia’s first fully fledged podiatry centre, and was an early adopter of cutting-edge technologies such as CAD/CAM custom-made orthotics and shockwave therapy. Reyneker’s dedication to innovation is further exemplified by his patented orthotic device, which has revolutionised treatment options for various foot conditions.

Catering to patients as young as six months and as old as 99 years, Family Podiatry Centre lives up to its name by addressing foot and leg conditions across all age groups. From ingrown toenail treatment to shin splints and corn removal, the clinic has cemented its reputation for providing effective, evidence-based solutions for diverse podiatric needs.

Reyneker’s recent research as part of his Master’s degree has further cemented his reputation as a thought leader in the field. His groundbreaking study revealed that human gait is variable rather than fixed, a discovery based on the analysis of Jomon-era fossils and later Stone Age remains. His colleague at Family Podiatry Centre, Kardem, also earned a Master’s in gait analysis, adding depth to the clinic’s expertise in understanding and treating biomechanical issues.

This recognition by Britishpedia is a testament to Reyneker’s long-standing dedication to elevating podiatry in the region, ensuring that Family Podiatry Centre remains a trusted destination for those seeking a skilled podiatrist in Singapore and exceptional care.

For further information or inquiries, please visit https://familypodiatrycentre.com/.

CreateAI Releases White Paper on how AI Transforms Animation Production

BEIJING, May 7, 2025 /PRNewswire/ — CreateAI Holdings Inc. (OTCMKTS: TSPH) (“CreateAI” or the “Company”), a global artificial intelligence technology company, today announced the release of its “White Paper on the Application and Development of Multimodal Generative Technology in Animation Production” (“White Paper”). The White Paper provides a comprehensive analysis of 2D and 3D animation production workflow, detailing the transformative impact of multimodal generative technology across critical stages, including scriptwriting, storyboarding, and asset creation for the animation industry.

CreateAI Releases White Paper on how AI Transforms Animation Production
CreateAI Releases White Paper on how AI Transforms Animation Production

The White Paper also highlights the global success of Ne Zha 2, a Chinese animated film that grossed over USD $2 billion, securing its place among the top five highest-grossing films in history globally and a breakthrough for Asia-origin studio work. As the first regional film to achieve this milestone, Ne Zha 2 leveraged cutting-edge AI generative tools to enhance animation quality, streamline production, and achieve widespread critical and commercial acclaim. The paper uses this landmark project as a case study, supported by robust data, to illustrate how AI drives cost-efficiency and creative innovation in the animation industry.

A key highlight of the White Paper is the introduction of CreateAI’s Video Model Evaluation System, the industry’s first standardized framework designed specifically for animation. This system establishes benchmarks for video generation across six essential dimensions, setting a new standard for quality and consistency in AI-driven animation.

“Technological progress must be anchored in real-world applications and sustainable business models,” said Cheng Lu, President and CEO of CreateAI. “The future of digital entertainment will be shaped not by generic large-scale models but by specialized solutions tailored to specific industry needs. CreateAI is dedicated to solving animation industry challenges, redefining creative workflows, and empowering artists to amplify – not replace – their vision through AI.”

Meeting Demand for Specialized Animation Tools

Despite rapid advancements in video generation models, generic tools often fall short of the animation industry’s need for precision, stylization, and seamless workflow integration. According to the Digital Content Association of Japan’s latest report, while global video model inference speeds have improved by 120%, creator satisfaction in animation applications remains below 31%. CreateAI addresses this gap with targeted, high-performance solutions.

Deep Strategic Deployment via Application

CreateAI has established a cohesive ecosystem integrating technology, tools, and content:

  • Technology: In December 2024, CreateAI unveiled Ruyi, a proprietary text-to-video model trained on specialized animation and sci-fi datasets. Ruyi addresses challenges like frame consistency and style adaptation, delivering dependable, high-quality outputs for creators.
  • Tools: CreateAI launched the world’s-first AI video generation platform tailored for anime, comics, and gaming (ACG) content – Animon.ai – developed with top Japanese animation teams. Offered via subscription, it supports unlimited high-quality video creation.
  • IP Ecosystem: CreateAI secured exclusive adaptation rights for Louis Cha’s “Heroes of Jin Yong” and The Three-Body Problem, iconic IPs with global cultural impact and loyal fanbases, driving significant market growth potential.

The full White Paper is available for free to download at https://d7bqhtsd96p14.cloudfront.net/upload/2025050612004141l72u.pdf

Simultaneous to the White Paper release, CreateAI hosted an investor event. To watch the speech during the event by Cheng Lu, President and CEO of CreateAI, please visit: https://youtu.be/87LUpHAWmAQ

About CreateAI

CreateAI (formerly TuSimple) is a global applied artificial intelligence company with offices in the US, China, and Japan. The Company has developed leading AI technology for a number of end-use applications. The Company is pioneering the future of digital entertainment content production, seamlessly blending cutting-edge generative AI technology with the creativity of world-class talent. Our mission is to redefine the boundaries of what’s possible in digital storytelling by developing immersive, captivating, and visually stunning experiences that resonate with audiences on a global scale. 

CreateAI Media Contact:
Brad Burgess
ICR, LLC
Email: CreateAI.PR@icrinc.com 

Flytxt announces strategic AI collaborations across key markets to drive co-innovation and value creation

DUBAI, UAE, May 7, 2025 /PRNewswire/ — Flytxt, a pioneer in Agentic AI solutions for subscription businesses, today announced a major initiative to expand its market footprint through a series of strategic go-to-market partnerships, unveiled at the SynergyX Partnership Day event on 28th April 2025 in Dubai. These partnerships are aimed at accelerating innovation across industries including telecom, BFSI, retail, government, hospitality, and healthcare, by embedding Flytxt’s AI into new use cases and solutions tailored for specific markets.

This announcement marks the formal launch of new partnerships across Europe, Middle East and Australia, with organizations that will drive the adoption of Flytxt’s AI in both public and private sectors. The collaborations are structured around mutual value creation—Flytxt brings the AI technology, while partners develop domain-specific use cases and drive go-to-market execution.

“These partnerships represent more than market expansion—they are a collective step toward redefining the potential of our AI across industries,” said Dr. Vinod Vasudevan, CEO of Flytxt. “Together with visionary partners, we are bringing Agentic AI to the forefront, turning data into autonomous decisions and actions at scale—unlocking new possibilities and accelerating value creation.”

Backed by a Decade of Deep AI R&D

Flytxt’s AI is built to perpetually train and sustain its performance in diverse environments. Flytxt AI is the result of over a decade of research guided by IIT Delhi, India, and TNO, The Netherlands. What makes Flytxt’s AI truly distinctive is its massive training on trillions of real-world data points across markets and use cases. At its core lies Flytxt’s proprietary Federated Learning Engine, which enables this continuous learning from localised datasets while ensuring strict data privacy and compliance. This architecture empowers the AI to continuously deliver superior contextual intelligence and accurate outcomes across use cases.

“Our AI is built not just to analyse—but to reason, decide, and act,” added Dr. Vinod. “The real measure of success is how many high-stake decisions and high-value use cases it can enable and how fast. These partnerships are the perfect catalyst for scalable innovation.”

Strategic Regional Partnerships

  • Europe: Profile as a Service GmbH (PaaS) is embedding Flytxt’s AI and CVM Solutions into its Reach-Me product line. In partnership with Aduna and Deutsche Telekom, PaaS aims to connect with up to 3 billion consumers. It creates a unique profile for consumers across channels, businesses, and locations—giving consumers full control over their personal data and enabling a 100% GDPR-compliant ecosystem for safe, meaningful engagement.
  • Middle East: Gulf Investment and Development LLC, owned by HH. Al Sayyid Badar Taimur Al Said, will develop digital transformation solutions leveraging Flytxt AI for Oman’s public sector as well as supply AI solutions to BFSI vertical. D8Hub and Octans Digital will include Flytxt AI into its Technology and CX transformation solutions for multiple industry verticals.
  • Australia: ePrimus led by Dr. Ravi Bhatia (former CEO, Primus Telecom), will co-develop AI applications along with Flytxt for Australia’s Telecom, Banking and Finance, Insurance, and Utilities sectors.

These strategic alliances mark a significant step in Flytxt’s mission to scale real-world impact—enabling faster AI adoption, broader industry applicability, and sustained business value through co-innovation.

About Flytxt

Flytxt is a pioneer in delivering massively trained Agentic AI solutions that drive measurable business outcomes for subscription businesses. Its AI is powered by a proprietary Federated Learning Engine that enables massive training across markets, while ensuring data security and compliance. Headquartered in Dubai, Flytxt collaborates with over 80 enterprises in more than 50 countries. Learn more at www.flytxt.ai.

Video: https://www.youtube.com/watch?v=KpxMMYVg3kw

 

Malaysia’s Leading Herbal Repair Cream Brand Enters Retail After 4 Years — and Customers Are Loving It

KUALA LUMPUR, Malaysia, May 7, 2025 /PRNewswire/ — After 4 years of selling exclusively online, Jolicare, Malaysia’s #1 selling herbal skincare brand for dry, itchy, and sensitive skin, is making its long-awaited debut in physical retail. The brand’s entry into nearly 20 stores across Klang Valley and Johor marks a significant milestone in its journey from an online startup to a household name, with over 100,000+ Jolicare Cream sold since its launch in 2021.

Malaysia’s Leading Herbal Repair Cream Brand Enters Retail After 4 Years — and Customers Are Loving It
Malaysia’s Leading Herbal Repair Cream Brand Enters Retail After 4 Years — and Customers Are Loving It

Founded in April 2021, Jolicare was born out of a simple but powerful belief: that people struggling with dry, itchy, and sensitive skin deserve more than just temporary relief. Over the years, its flagship product, Jolicare Cream, has become known for providing Lasting Repair — a steroid-free, herbal formulation trusted by families across Malaysia and Singapore.

The decision to enter physical retail wasn’t made lightly. For the past four years, Jolicare has built its community entirely through digital channels — including Shopee, TikTok Shop, Lazada, and its own website — with over 20,000+ 5-star reviews and customer stories shaping the brand’s growth.

Jolicare’s rise has been quietly impressive. With over 539% year-on-year growth, the brand’s momentum reflects a growing demand for lasting, herbal-based solutions.

But beyond numbers, it’s the voices of customers — thoughtful reviews, heartfelt stories, and consistent repurchases — that continue to shape the brand’s journey. Many of these customers, especially those looking for gentler, effective everyday skincare for their dry, itchy, and sensitive skin, have been asking for one thing: easier access.

Therefore, this decision to move into retail is not one driven by the company, but the customers.

“We’ve received thousands of messages from customers who love Jolicare but prefer buying in-store,” said Caleb, CEO of Jolicare.

“Tons of them say – We need the cream urgently. Is there a place we can get it now?” 

“Some don’t shop online, others want to feel the product before purchasing, and many simply enjoy browsing at their favorite pharmacy.”

“It’s time to make Jolicare more accessible.” Caleb added.

In just 45 days, Jolicare rolled out to nearly 20 outlets, with many more to come. The brand is already in talks to expand into 1,000 retail stores across Malaysia & Singapore in 2025, signaling a significant wave of momentum for Jolicare.

The team shared that walk-in customers have already expressed excitement at discovering the brand on shelves, especially those experiencing skin issues such as eczema, psoriasis, or dry, itchy, and sensitive skin.

Jolicare Cream is designed to provide herbal, lasting repair with every use:

  • Formulated with 10+ Premium Herbs
  • 0 Steroids. 0 Parabens. 0 Fragrances.
  • GMP-certified
  • Lab-tested and certified by SGS and MyCO2
  • 20,000+ five-star reviews

What’s next for Jolicare?

While the brand is keeping some details under wraps, pharmacy partnerships are on the horizon, and customers may soon find Jolicare at some of the country’s best-known pharmacy chains.

“We’ll leave that part as a little surprise.   But one thing’s for sure — Jolicare is just getting started,” Caleb added with a little wink.

To learn more about Jolicare, visit the official website: https://jolicare.com

About Jolicare

Jolicare is the #1 selling repair cream for dry, itchy, and sensitive skin in Malaysia and Singapore. With over 100,000+ creams sold and thousands of loyal customers, Jolicare continues to expand its presence both online and offline across Malaysia, Singapore, and beyond.

Follow Jolicare on Social Media:

Facebook: /jolicare.os
Instagram: @jolicare.os
TikTok: @jolicare.my